Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Huff

Showing results (211-220 of 267) with videos related to

Pageof 27
Sort By:
Alzheimer Disease and Associated Disorders|January 1, 1997
Diagnostic criteria for dementia in clinical trials. Position paper from the International Working Group on Harmonization of Dementia Drug GuidelinesP Antuono, R Doody, S Gilman, et al.
Journal of Toxicology and Environmental Health|November 1, 1990
Neurotoxicity and carcinogenicity of N-methylolacrylamide in F344 rats and B6C3F1 miceJ R Bucher, J Huff, J K Haseman, et al.
Molecular Carcinogenesis|January 1, 1993
Cell proliferation and chemical carcinogenesis: a symposium overviewR L Melnick, J Huff, J C Barrett, et al.
Environmental Health Perspectives|December 1, 1993
Cell proliferation and chemical carcinogenesis: symposium overviewR L Melnick, J Huff, J C Barrett, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
BiomarkersAllison J Huff, Juyoung Park, Samuel Montero-Hernandez, et al.
Neuroimage. Reports|October 6, 2025
Functional near-infrared spectroscopy (fNIRS) detects brain changes for apathy and pain in patients with Alzheimer's disease and related dementias: An exploratory studyAllison J Huff, Juyoung Park, Samuel Montero-Hernandez, et al.
Cancer Research|April 1, 1978
Evaluation of the carcinogenicity of chemicals: a review of the Monograph Program of the International Agency for Research on Cancer (1971 to 1977)L Tomatis, C Agthe, H Bartsch, et al.
The American Journal of Psychiatry|March 1, 1996
Prospective study of increased platelet membrane fluidity as a risk factor for Alzheimer's disease: results at 5 yearsG S Zubenko, I Teply, E Winwood, et al.
Cancer Research|December 1, 1986
Forestomach lesions in rats and mice administered 3-chloro-2-methylpropene by gavage for two yearsP C Chan, J K Haseman, G A Boorman, et al.
Archives of Neurology|October 1, 1990
Brain imaging abnormalities in mental disorders of late lifeG S Zubenko, P Sullivan, J P Nelson, et al.
Pageof 27

Showing results (211-220 of 267) with videos related to

Sort By:
Pageof 27
Alzheimer Disease and Associated Disorders|January 1, 1997
Diagnostic criteria for dementia in clinical trials. Position paper from the International Working Group on Harmonization of Dementia Drug GuidelinesP Antuono, R Doody, S Gilman, et al.
Journal of Toxicology and Environmental Health|November 1, 1990
Neurotoxicity and carcinogenicity of N-methylolacrylamide in F344 rats and B6C3F1 miceJ R Bucher, J Huff, J K Haseman, et al.
Molecular Carcinogenesis|January 1, 1993
Cell proliferation and chemical carcinogenesis: a symposium overviewR L Melnick, J Huff, J C Barrett, et al.
Environmental Health Perspectives|December 1, 1993
Cell proliferation and chemical carcinogenesis: symposium overviewR L Melnick, J Huff, J C Barrett, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
BiomarkersAllison J Huff, Juyoung Park, Samuel Montero-Hernandez, et al.
Neuroimage. Reports|October 6, 2025
Functional near-infrared spectroscopy (fNIRS) detects brain changes for apathy and pain in patients with Alzheimer's disease and related dementias: An exploratory studyAllison J Huff, Juyoung Park, Samuel Montero-Hernandez, et al.
Cancer Research|April 1, 1978
Evaluation of the carcinogenicity of chemicals: a review of the Monograph Program of the International Agency for Research on Cancer (1971 to 1977)L Tomatis, C Agthe, H Bartsch, et al.
The American Journal of Psychiatry|March 1, 1996
Prospective study of increased platelet membrane fluidity as a risk factor for Alzheimer's disease: results at 5 yearsG S Zubenko, I Teply, E Winwood, et al.
Cancer Research|December 1, 1986
Forestomach lesions in rats and mice administered 3-chloro-2-methylpropene by gavage for two yearsP C Chan, J K Haseman, G A Boorman, et al.
Archives of Neurology|October 1, 1990
Brain imaging abnormalities in mental disorders of late lifeG S Zubenko, P Sullivan, J P Nelson, et al.
Pageof 27